Sign in

CIK 0001752828 · <br>Emerging growth company

Celularity Inc

Sign in to watch
Ticker
CELU
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
831702591
Phone
(908) 768-2170
Business address
170 PARK AVE, FLORHAM PARK, NJ, 07932
Former names
GX Acquisition Corp.
  1. 424B3 Offering Prospectus
  2. 8-K Event Results of operations
  3. 10-Q Report Quarterly Report
  4. 424B3 Offering Prospectus
  5. 424B3 Offering Prospectus
  6. 8-K Event Executive or director change
  7. 4 Grant or award Director acquired 36,145 shares (grant or award)
  8. 4 Grant or award Director acquired 36,145 shares (grant or award)
  9. 4 Grant or award Director acquired 36,145 shares (grant or award)
  10. 4 Grant or award Director acquired 36,145 shares (grant or award)
  11. 4 Grant or award Chief Technology Officer acquired 13,124 shares (grant or award)
  12. 4 Grant or award Director acquired 36,145 shares (grant or award)
  13. 4 Grant or award Director acquired 36,145 shares (grant or award)
  14. 4 Grant or award Chief Business Officer acquired 11,483 shares (grant or award)
  15. 4 Grant or award General Counsel acquired 2,297 shares (grant or award)
  16. 4 Grant or award Director acquired 36,145 shares (grant or award)
  17. 4 Grant or award Director acquired 36,145 shares (grant or award)
  18. 3 Insider Initial Statement of Ownership
  19. 10-K/A Report 10-K/A
  20. 424B3 Offering Prospectus

Page 16 of 29 · 563 filings